pembrolizumab,lenvatinib
merck,eisai
['lenva', 'rcc,(-irccs),(-srcc),(-urcc)', 'pembro']
 gives a wonderful talk #esmo22 in nccrcc with pembro/lenvatinib with about half of pts responding! waterfall plot impressive! toxicity needs attention. chromophobe remains a highly unmet need! 
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine